| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |